R

Rekah Pharmaceutical Industry Ltd
TASE:REKA

Watchlist Manager
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Watchlist
Price: 1 481 ILS -1.2% Market Closed
Market Cap: 175.3m ILS
Have any thoughts about
Rekah Pharmaceutical Industry Ltd?
Write Note

Rekah Pharmaceutical Industry Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rekah Pharmaceutical Industry Ltd
Revenue Peer Comparison

Comparables:
TEVA
SLGL
I
INCR
MDWD
S
SEMG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Revenue
â‚Ş324.4m
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
2%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Revenue
$16.3B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Revenue
$6.6m
CAGR 3-Years
4%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
I
InterCure Ltd
TASE:INCR
Revenue
â‚Ş355.6m
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
45%
Mediwound Ltd
NASDAQ:MDWD
Revenue
$20.1m
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
72%
S
Seach Medical Group Ltd
TASE:SEMG
Revenue
â‚Ş162.4m
CAGR 3-Years
61%
CAGR 5-Years
66%
CAGR 10-Years
64%

See Also

What is Rekah Pharmaceutical Industry Ltd's Revenue?
Revenue
324.4m ILS

Based on the financial report for Jun 30, 2024, Rekah Pharmaceutical Industry Ltd's Revenue amounts to 324.4m ILS.

What is Rekah Pharmaceutical Industry Ltd's Revenue growth rate?
Revenue CAGR 10Y
2%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Rekah Pharmaceutical Industry Ltd have been 6% over the past three years , 11% over the past five years , and 2% over the past ten years .

Back to Top